𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pathologic prognostic factors for cutaneous malignant melanoma: The western canada melanoma study

✍ Scribed by Ann J. Worth; Richard P. Gallagher; J. Mark Elwood; Paul C. Yang; Charles Lamb; John J. Spinelli; William S. Wood; William J. Threlfall; Gerry B. Hill

Publisher
John Wiley and Sons
Year
1989
Tongue
French
Weight
529 KB
Volume
43
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis

An analysis of data for histopathologic factors influencing survival was conducted on 798 cases of invasive cutaneous malignant melanoma. On univariate analysis, a number of factors influenced survival; however, when these factors were examined using a proportional-hazards model, sex and log of depth of penetration were the only factors governing survival. Moreover, these factors were only important in patients with lesions up to 4 mm in depth with no evidence of other disease. For patients with solitary lesions deeper than 4 mm, or patients with regional or distant disease, none of the factors examined in our study was of predictive value for survival assessment.

πŸ“œ SIMILAR VOLUMES

Prognostic factors for cutaneous maligna
Prognostic factors for cutaneous malignant melanoma in Vaud, Switzerland
✍ Fabio Levi; Lalao Randimbison; Carlo La Vecchia; Van-Cong Te; Silvia Franceschi πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 French βš– 72 KB πŸ‘ 2 views

We considered, by means of a multivariate approach, trends in survival from cutaneous malignant melanoma in relation to patient and tumor characteristics, using data from the Cancer Registry of the Swiss Canton of Vaud. Between 1980 and 1994, 1,229 cases of incident cutaneous malignant melanoma were

Cutaneous melanoma in relation to interm
Cutaneous melanoma in relation to intermittent and constant sun exposureβ€”the western canada melanoma study
✍ J. M. Elwood; R. P. Gallagher; G. B. Hill; J. C. G. Pearson πŸ“‚ Article πŸ“… 1985 πŸ› John Wiley and Sons 🌐 French βš– 725 KB

## Abstract The histories of exposure to sun through occupational, recreational and vacation activities of 595 patients with newly incident cutaneous melanoma excluding lentigo maligna and acral lentiginous melanoma, were compared to those of comparison subjects drawn randomly from the same populat

Invasive cutaneous malignant melanoma in
Invasive cutaneous malignant melanoma in Sweden, 1990–1999 : A prospective, population-based study of survival and prognostic factors
✍ Christer Lindholm; Ronny Andersson; Monika Dufmats; Johan Hansson; Christian Ing πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 268 KB πŸ‘ 2 views

## Abstract ## BACKGROUND The objective of the current study was to compile prospective, population‐based data on cutaneous invasive melanomas in Sweden during the period from 1990 to 1999, to describe and analyze survival data and prognostic factors, and to make comparisons with previously publis

The Danish case-control study of cutaneo
The Danish case-control study of cutaneous malignant melanoma. I. Importance of host factors
✍ A. Østerlind; M. A. Tucker; K. Hou-Jensen; B. J. Stone; G. Engholm; O. M. Jensen πŸ“‚ Article πŸ“… 1988 πŸ› John Wiley and Sons 🌐 French βš– 719 KB

The relationship between cutaneous malignant melanoma and possible host factors was investigated in a populationbased case-control study from East Denmark over a 3-year period. A total of 474 melanoma patients and 926 population controls aged 20-79 years were interviewed. Patients with lentigo malig

Cutaneous malignant melanoma. II. The na
Cutaneous malignant melanoma. II. The natural history and prognostic factors influencing the development of stage II disease
✍ Donald H. Berdeaux; Frank L. Meyskens Jr; Bruce Parks; Tony Tong; Lois Loescher; πŸ“‚ Article πŸ“… 1989 πŸ› John Wiley and Sons 🌐 English βš– 722 KB

The survival history of 259 patients with Stage I cutaneous malignant melanoma who were at risk for developing regional nodal metastases (Stage 11) were studied. Eighty-seven of 377 Stage I patients (23%) developed regional nodal metastases (Stage IIB) with 40% 5-year survival. Fifty patients had re